Tag:
Nuedexta
Latest Headlines
Latest Headlines
Nuedexta next in line for congressional questions
U.S. lawmakers haven't limited their latest pricing crusade to URL Pharma's Colcrys. As the Wall Street Journal Health Blog reports, the same group of congressional members who wrote URL to question
Avanir cranks up sales force for Nuedexta
Now that it has its FDA approval for Nuedexta in the bag, Avanir Pharmaceuticals ( $AVNR ) is switching into marketing mode. The drug, approved to treat pseudobulbar affect (PBA), is the first
